Literature DB >> 6989448

Inhibition of in situ metabolism of [3H](met5)-enkephalin and potentiation of (met5)-enkephalin analgesia by captopril.

S M Stine, H Y Yang, E Costa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6989448     DOI: 10.1016/0006-8993(80)90581-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


× No keyword cloud information.
  7 in total

1.  Degradation of Met-enkephalin by hemolymph peptidases in Mytilus edulis.

Authors:  M K Leung; S Le; S Houston; G B Stefano
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

2.  Potentiation of [Met5]enkephalin-induced antinociception by mixture of three peptidase inhibitors in rat.

Authors:  Tomohiko Murata; Masanobu Yoshikawa; Mariko Watanabe; Shigeru Takahashi; Mitsuru Kawaguchi; Hiroyuki Kobayashi; Toshiyasu Suzuki
Journal:  J Anesth       Date:  2014-04-05       Impact factor: 2.078

3.  The influence of naloxone on the circulatory effects of captopril.

Authors:  P C Rubin; J A Millar; S Sturani; C Lawrie; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

4.  Nootropic effects of ACE inhibitors in mice.

Authors:  C Mondadori; P Etienne
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Captopril and opiate antagonism in essential hypertension.

Authors:  A A Ajayi; P C Rubin; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

Review 6.  Degradation of enkephalins: the search for an enkephalinase.

Authors:  L B Hersh
Journal:  Mol Cell Biochem       Date:  1982-08-20       Impact factor: 3.396

7.  Naloxone does not antagonize the antihypertensive effect of chronic captopril therapy in hypertensive patients.

Authors:  G P Bernini; A R Lucarini; M S Vivaldi; C Del Corso; M Lenzi; A Salvetti
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.